Marksans Pharma Limited (MARKSANS.NS) Financials
MARKSANS.NS Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| Sept. 30, 2026 | 43.6 billion | 9.9 billion |
| June 30, 2026 | ? | -30.5 billion |
| March 31, 2026 | 38.6 billion | 8.1 billion |
| Dec. 31, 2025 | ? | -27.1 billion |
MARKSANS.NS Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| Sept. 30, 2026 | ? | ? |
| June 30, 2026 | ? | ? |
| March 31, 2026 | ? | ? |
| Dec. 31, 2025 | ? | ? |
MARKSANS.NS Net Income
Graph available only for paid members. Upgrade to see it.
| Date | Net Income |
|---|---|
| Sept. 30, 2026 | 1.4 billion |
| June 30, 2026 | 1.6 billion |
| March 31, 2026 | 1.5 billion |
| Dec. 31, 2025 | 1.1 billion |
MARKSANS.NS Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| Sept. 30, 2026 | 11.2 billion | - | 3.9 billion |
| June 30, 2026 | 9.9 billion | - | - |
| March 31, 2026 | 9.9 billion | - | 3.1 billion |
| Dec. 31, 2025 | 6.7 billion | - | - |
MARKSANS.NS Shares Outstanding
MARKSANS.NS Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| Sept. 30, 2026 | - | 239.0 million | 1.9 billion | - |
| June 30, 2026 | - | 232.0 million | 1.5 billion | - |
| March 31, 2026 | - | - | 1.6 billion | - |
| Dec. 31, 2025 | - | 358.0 million | 1.3 billion | - |
MARKSANS.NS Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| Sept. 30, 2026 | 9.4 billion | 5.4 billion |
| June 30, 2026 | 8.4 billion | 4.8 billion |
| March 31, 2026 | 8.6 billion | 5.2 billion |
| Dec. 31, 2025 | 7.5 billion | 4.5 billion |
MARKSANS.NS
Price: ₹291.15
52 week price:
Forward Dividend Yield: 0.31%
Payout Ratio: 8.16%
Payout Ratio Range:
Dividend Per Share: 0.90 INR
Earnings Per Share: 12.35 INR
P/E Ratio: 25
Exchange: NSI
Sector: Healthcare
Industry: Drug Manufacturers - General
Market Capitalization: 139.9 billion
Average Dividend Frequency: 1
Years Paying Dividends: 13